| Literature DB >> 29160465 |
Orlando Mario Soeiro1, Noêmia Urruth Leão Tavares2, José Miguel do Nascimento3, Augusto Afonso Guerra4, Ediná Alves Costa5, Francisco de Assis Acurcio4, Ione Aquemi Guibu6, Juliana Álvares4, Margô Gomes de Oliveira Karnikowski7, Silvana Nair Leite8, Karen Sarmento Costa9,10,11.
Abstract
OBJECTIVE: To evaluate patient satisfaction with pharmaceutical services in Brazilian primary health care.Entities:
Mesh:
Year: 2017 PMID: 29160465 PMCID: PMC5676369 DOI: 10.11606/S1518-8787.2017051007145
Source DB: PubMed Journal: Rev Saude Publica ISSN: 0034-8910 Impact factor: 2.106
Questions considered in the analysis of patient satisfaction with pharmaceutical services in the primary health care, according to aspects and sub-aspects, and categorization for the item response theory model. National Survey on Access, Use and Promotion of Rational Use of Medicines – Services, 2015.
| Questions | Categorization |
|---|---|
|
| |
| Is this place far from your house? | Assume value |
|
| “Very easy” and “Easy” received code |
|
| “Very good” and “good” received code |
|
| The answers “do not wait” and “a little” received code |
|
| |
|
| The answers “Pharmacy of the SUS,” “Popular Pharmacy Program,” or “Church or Union” received code |
| Did you have any problems to get the medicine the last time? | The answers “did not have problems” received code |
|
| “No” had value |
|
| The answers “always” and “repeatedly” received code |
|
| The answer “no” received code |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
| When you obtain the medicines in the public pharmacies of SUS, do the public employees who deliver the medicines give you information about their use? | The answer “yes” received code |
| Do you understand the information given by employees who deliver the medicines in the public pharmacies of SUS? | The answers “always” and “repeatedly” received code |
| Is the pharmacist or another employee from the public pharmacy of SUS available when you need to ask questions about the medicines? | |
| Quality of medicines sub-aspect | The answer “well” received code |
| In your opinion, is this medicine causing you any health problems? | The answer “no” received code |
| For you, the effects of medicines obtained in public pharmacies of SUS compared to the effects of medicines bought in commercial pharmacies are: | “The same” and “better” received code |
| When you obtain medicines in public pharmacies of SUS, do you receive information on how to store them at home? | The answers “always” and “repeatedly” received code |
| Ambiance Sub-aspect | |
|
| “Very easy” and “easy” received code |
|
| The answers “very good” and “good” received code |
|
| The answers “very good” and “good” received code |
|
| |
|
| |
|
| The answers “always” and “frequently” received code |
| Do you consider that the service provided at the pharmacy of SUS respects your privacy? | |
|
| The answers “very good” and “good” received code |
SUS: Brazilian Unified Health System
FigureProportion of patients satisfied with pharmaceutical services in primary health care according to the aspects and sub-aspects. National Survey on Access, Use and Promotion of Rational Use of Medicines – Services, 2015.
Multiple logistic model of patient satisfaction with pharmaceutical services in the primary health care regarding the aspects, sub-aspects, and overall satisfaction, according to sociodemographic characteristics. National Survey on Access, Use and Promotion of Rational Use of Medicines – Services, 2015.
| Variable | Opportunity/Convenience (n = 4,441) | Availability (n = 4,620) | Quality of medicines (n = 4,886) | Ambiance (n = 2,852) | Interpersonal aspects (n = 5,060) | Overall satisfaction (n = 4,768) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |||||||||||||
| ORa | 95%CI | p | ORa | 95%CI | p | ORa | 95%CI | p | ORa | 95%CI | p | ORa | 95%CI | p | ORa | 95%CI | p | |
| Sex | ||||||||||||||||||
| Male | 1.165 | (1.013–1.339) | 0.032 | 1.269 | (1.081–1.488) | 0.003 | 1.190 | (1.028–1.378) | 0.022 | 1.261 | (1.087–1.464) | 0.002 | ||||||
| Female | 1 | - | - | 1 | - | - | - | - | - | - | - | - | 1 | - | - | 1 | - | - |
| Age group (years) | - | - | - | - | ||||||||||||||
| 18 to 29 | 1 | - | - | - | - | - | 1 | - | - | 1 | - | - | 1 | - | - | 1 | - | - |
| 30 to 49 | 1.054 | (0.889–1.250) | 0.543 | - | - | - | 1.173 | (0.975–1.412) | 0.091 | 1.105 | (0.921–1.325) | 0.283 | 1.263 | (0.933–1.708) | 0.13 | 1.215 | (1.007–1.466) | 0.043 |
| 50 to 69 | 1.602 | (1.288–1.993) | < 0.001 | - | - | - | 1.562 | (1.288–1.893) | < 0.001 | 1.553 | (1.206–1.999) | 0.001 | 1.645 | (1.098–2.463) | 0.016 | 1.766 | (1.387–2.248) | < 0.001 |
| 70 or more | 1.994 | (1.494–2.661) | < 0.001 | - | - | - | 2.275 | (1.584–3.269) | < 0.001 | 1.911 | (1.371–2.664) | < 0.001 | 2.081 | (1.085–3.994) | 0.028 | 2.222 | (1.628–3.031) | < 0.001 |
| Skin color | ||||||||||||||||||
| Nonwhite | - | - | - | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| White | - | - | - | 1.238 | (1.041–1.472) | 0.016 | - | - | - | - | - | - | - | - | - | - | - | - |
| Education level | ||||||||||||||||||
| Illiterate | 1 | - | - | 1 | - | - | - | - | - | 1.568 | (1.005–2.447) | 0.048 | 2.156 | (1.208–3.848) | 0.01 | - | - | - |
| Elementary school | 1.098 | (0.811–1.488) | 0.545 | 1.851 | (1.364–2.513) | < 0.001 | - | - | - | 1.697 | (1.203–2.393) | 2.116 | (1.407–3.182) | < 0.001 | - | - | - | |
| High School | 1.206 | (0.861–1.691) | 0.277 | 1.962 | (1.501–2.566) | < 0.001 | - | - | - | 1.217 | (0.849–1.744) | 0.285 | 1.4 | (0.879–2.230) | 0.157 | - | - | - |
| Higher Education | 1.365 | (0.931–2.003) | 0.112 | 1.737 | (1.187–2.542) | 0.005 | - | - | - | 1 | - | - | 1 | - | - | - | - | - |
| ABEP classificationb | ||||||||||||||||||
| A or B | - | - | - | - | - | - | 1 | - | - | - | - | - | - | - | - | - | - | - |
| C | - | - | - | - | - | - | 1.243 | (1.042–2.483) | 0.016 | - | - | - | - | - | - | - | - | - |
| D or E | - | - | - | - | - | - | 1.473 | (1.170–1.854) | 0.001 | - | - | - | - | - | - | - | - | - |
| Region of residence | ||||||||||||||||||
| Midwest | 1 | - | - | 1 | - | - | 1 | - | - | 1 | - | - | 1 | - | - | 1 | - | - |
| North | 0.768 | (0.532–1.109) | 0.160 | 1.341 | (0.759–2.370) | 0.312 | 1.315 | (0.926–1.867) | 0.126 | 1.05 | (0.600–1.836) | 0.865 | 0.884 | (0.563–1.390) | 0.594 | 1.255 | (0.947–1.662) | 0.114 |
| Northeast | 1.118 | (0.782–1.600) | 0.541 | 1.882 | (1.091–3.247) | 0.023 | 2.049 | (1.364–3.080) | 0.002 | 1.291 | (0.779–2.142) | 0.321 | 0.998 | (0.640–1.555) | 0.993 | 1.209 | (0.805–1.815) | 0.360 |
| South | 0.994 | (0.760–1.301) | 0.968 | 1.484 | (0.837–2.633) | 0.177 | 1.610 | (1.000–2.592) | 0.050 | 1.373 | (0.871–2.167) | 0.172 | 1.067 | (0.707–1.607) | 0.758 | 1.155 | (0.788–1.691) | 0.461 |
| Southeast | 0.990 | (0.744–1.317) | 0.946 | 1.945 | (1.133–3.339) | 0.016 | 1.549 | (1.025–2.340) | 0.038 | 2.066 | (1.289–3.312) | 1.422 | (0.945–2.140) | 0.091 | 1.596 | (1.060–2.402) | 0.025 | |
a Significant variables at the 5% level after adjusted analysis.
b Brazil Economic Classification Criteria – Brazilian Market Research Association – ABEP 2013 – www.abep.org
Multiple logistic model of patient satisfaction with pharmaceutical services in the primary health care regarding the aspects, sub-aspects, and overall satisfaction, according to health and service use characteristics. PNAUM – Services, Brazil 2015.
| Variable | Opportunity/Convenience (n = 4,441) | Availability (n = 4,620) | Quality of medicines (n = 4,886) | Ambiance (n = 2,852) | Interpersonal aspects (n = 5,060) | Overall satisfaction (n = 4,768) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |||||||||||||
| OR* | 95%CI | p | OR* | 95%CI | p | OR* | 95%CI | p | OR* | 95%CI | p | OR* | 95%CI | p | OR* | 95%CI | p | |
| Number of emergency health services in the past 12 months* | ||||||||||||||||||
| None | - | - | - | 1.887 | (1.487–2.395) | < 0.001 | 1.489 | (1.130–1.961) | 0.028 | 1.896 | (1.437–2.502) | < 0.001 | 2.551 | (1.781–3.652) | < 0.001 | 1.801 | (1.383–2.346) | < 0.001 |
| One | - | - | - | 1.453 | (1.124–1.879) | 0.004 | 1.145 | (0.908–1.444) | 0.253 | 1.700 | (1.220–2.370) | 0.002 | 2.003 | (1.346–2.981) | < 0.001 | 1.657 | < 0.001 | |
| Two or more | - | - | - | 1 | - | - | 1 | - | - | 1 | - | - | 1 | - | - | 1 | - | - |
| Self-perception of health* | ||||||||||||||||||
| Very good | 2.051 | (1.235–3.405) | 0.006 | 1.820 | (0.917–3.612) | 0.087 | 2.027 | (1.080–3.803) | 0.028 | - | - | - | - | - | - | 2.036 | (1.163–3.564) | 0.014 |
| Good | 1.697 | (1.035–2.782) | 0.036 | 2.288 | (1.221–4.287) | 0.010 | 1.486 | (0.890–2.481) | 0.130 | - | - | - | - | - | - | 1.729 | (1.037–2.883) | 0.036 |
| Regular | 1.246 | (0.776–2.000) | 0.364 | 1.727 | (0.949–3.141) | 0.074 | 1.079 | (0.633–1.838) | 0.781 | - | - | - | - | - | - | 1.294 | (0.783–2.138) | 0.315 |
| Bad | 1.152 | (0.696–1.907) | 0.581 | 1.257 | (0.659–2.398) | 0.487 | 0.981 | (0.587–1.641) | 0.943 | - | - | - | - | - | - | 1.048 | (0.583–1.887) | 0.875 |
| Very bad | 1 | - | - | 1 | - | - | 1 | - | - | - | - | - | - | - | - | 1 | - | - |
| Limitations due to disease* | ||||||||||||||||||
| No | 1.278 | (1.092–1.495) | 0.002 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Yes | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Pain and malaise* | ||||||||||||||||||
| No | - | - | - | 1.496 | (1.232–1.818) | < 0.001 | 1.441 | (1.224–1.697) | < 0.001 | 1.574 | (1.288–1.924) | < 0.001 | 1.628 | (1.238–2.141) | < 0.001 | 1.486 | (1.271–1.736) | < 0.001 |
| Yes | - | - | - | 1 | - | - | 1 | - | - | 1 | - | - | 1 | - | - | 1 | - | - |
| Anxiety and depression* | ||||||||||||||||||
| No | - | - | - | - | - | - | 1.212 | (1.025–1.432) | 0.025 | - | - | - | 1.352 | (1.053–1.736) | 0.018 | - | - | - |
| Yes | - | - | - | - | - | - | 1 | - | - | - | 1 | - | - | - | - | - | ||
| Number of medicines | ||||||||||||||||||
| 0 | - | - | - | 2.660 | (1.678–4.216) | < 0.001 | 1.262 | (0.849–1.876) | 0.250 | - | - | - | - | - | - | - | - | - |
| 1 | - | - | - | 2.360 | (1.602–3.478) | < 0.001 | 1.614 | (1.144–2.277) | 0.007 | - | - | - | - | - | - | - | - | - |
| 2 | - | - | - | 1.676 | (1.192–2.358) | 1.174 | (0.856–1.610) | 0.319 | - | - | - | - | - | - | - | - | - | |
| 3 | - | - | - | 1.450 | (1.016–2.070) | 0.041 | 1.031 | (0.764–1.393) | 0.841 | - | - | - | - | - | - | - | - | - |
| 4 | - | - | - | 1.452 | (1.009–2.088) | 0.045 | 0.964 | (0.695–1.337) | 0.824 | - | - | - | - | - | - | - | - | - |
| 5 or more | - | - | - | 1 | - | - | 1 | - | - | - | - | - | - | - | - | - | - | - |
* Significant variables at the 5% level after adjusted analysis.